- $12.06bn
- $12.89bn
- $2.96bn
- 86
- 15
- 92
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,073 | 1,988 | 2,418 | 2,531 | 2,965 |
Cost of Revenue | |||||
Gross Profit | 995 | 940 | 1,210 | 1,307 | 1,517 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,772 | 1,739 | 2,005 | 2,098 | 2,384 |
Operating Profit | 301 | 248 | 413 | 433 | 581 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 280 | 226 | 394 | 414 | 544 |
Provision for Income Taxes | |||||
Net Income After Taxes | 198 | 161 | 281 | 298 | 427 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 197 | 158 | 277 | 297 | 427 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 197 | 158 | 277 | 297 | 427 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.3 | 1.13 | 1.89 | 2.12 | 2.4 |
Dividends per Share |